Colorectal cancer (CRC) with a high prevalence is recognized as the fourth most common cause of cancer‐related death globally. Over the past decade, there has been growing interest in the… Click to show full abstract
Colorectal cancer (CRC) with a high prevalence is recognized as the fourth most common cause of cancer‐related death globally. Over the past decade, there has been growing interest in the network of tumor cells, stromal cells, immune cells, blood vessel cells, and fibroblasts that comprise the tumor microenvironment (TME) to identify new therapeutic interventions.
               
Click one of the above tabs to view related content.